Latest filings (excl ownership)
S-4
Registration of securities issued in business combination transactions
27 Jun 24
8-K
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
27 Jun 24
8-K
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
21 Jun 24
10-K
2024 FY
Annual report
21 Jun 24
8-K
Regulation FD Disclosure
1 Apr 24
8-K
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
12 Feb 24
10-Q
2024 Q3
Quarterly report
12 Feb 24
8-K
Departure of Directors or Certain Officers
8 Jan 24
8-K
Changes in Registrant's Certifying Accountant
15 Dec 23
10-Q
2024 Q2
Quarterly report
13 Nov 23
8-K
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
13 Nov 23
8-K
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
23 Oct 23
EFFECT
Notice of effectiveness
17 Oct 23
424B3
Prospectus supplement
16 Oct 23
CORRESP
Correspondence with SEC
12 Oct 23
UPLOAD
Letter from SEC
12 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
11 Oct 23
D
$15.12 mm in equity / options / securities to be acquired, sold $7.50 mm, 4 investors
10 Oct 23
S-3
Shelf registration
6 Oct 23
8-K
Acasti Announces $7.5 Million Private Placement Equity Financing
26 Sep 23
S-8
Registration of securities for employees
25 Aug 23
DEFA14A
Additional proxy soliciting materials
25 Aug 23
DEF 14A
Definitive proxy
25 Aug 23
8-K
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
11 Aug 23
10-Q
2024 Q1
Quarterly report
11 Aug 23
8-K
Other Events
24 Jul 23
8-K
Acasti Pharma Announces 1-for-6 Reverse Stock Split
7 Jul 23
8-K
Other Events
5 Jul 23
8-K
Acasti Pharma Reports Fiscal Year 2023 Operational Results
23 Jun 23
10-K
2023 FY
Annual report
23 Jun 23
8-K
Departure of Directors or Certain Officers
11 May 23
8-K
Acasti Announces Appointment of Prashant Kohli as CEO
5 Apr 23
8-K
Departure of Directors or Certain Officers
31 Mar 23
8-K
Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange
13 Mar 23
8-K
Changes in Registrant's Certifying Accountant
22 Feb 23
8-K
Acasti Pharma Reports Third Quarter 2023 Operational Results
14 Feb 23
10-Q
2023 Q3
Quarterly report
14 Feb 23
8-K
Other Events
25 Jan 23
8-K
Other Events
28 Dec 22
8-K
Other Events
22 Dec 22
Latest ownership filings
4/A
Carrie D'Andrea
10 May 24
4/A
Amresh Kumar
10 May 24
4
Carrie D'Andrea
8 May 24
4
Amresh Kumar
8 May 24
4
R. Loch Macdonald
8 May 24
4
Robert J DelAversano
8 May 24
4
Prashant Kohli
8 May 24
SC 13G
HIRSCHMAN ORIN
9 Apr 24
SC 13G
BANK OF AMERICA CORP /DE/
13 Feb 24
3
Robert J DelAversano
8 Jan 24
4
Vimal Kavuru
20 Dec 23
4
George Kottayil
20 Dec 23
4
EDWARD NEUGEBOREN
20 Dec 23
4
A BRIAN DAVIS
20 Dec 23
4
Prashant Kohli
20 Dec 23
3
George Kottayil
20 Oct 23
3
EDWARD NEUGEBOREN
20 Oct 23
3
A BRIAN DAVIS
20 Oct 23
4
Vimal Kavuru
27 Sep 23
4
Donald Olds
5 Sep 23
4
Michael Derby
18 Jul 23
4
Vimal Kavuru
18 Jul 23
4
Donald Olds
18 Jul 23
4
R. Loch Macdonald
18 Jul 23
4
Carrie D'Andrea
18 Jul 23
4
Amresh Kumar
18 Jul 23
4
Prashant Kohli
18 Jul 23
3
R. Loch Macdonald
26 May 23
3
Carrie D'Andrea
18 May 23
3
Amresh Kumar
18 May 23
4
Vimal Kavuru
30 Sep 22
4
Donald Olds
30 Sep 22
4
John Canan
30 Sep 22
4
Michael Derby
30 Sep 22
3
Prashant Kohli
16 Sep 22
4
Pierre Lemieux
23 Jun 22
4
George Kottayil
23 Jun 22
4
Brian D. Ford
23 Jun 22
4
Janelle D'Alvise
23 Jun 22
3
Michael Derby
1 Apr 22